Multilevel predictors of colorectal cancer testing modality among publicly and privately insured people turning 50

Preventive Medicine Reports

Volumn 6, Issue , 2017, Pages 9-16

  Wheeler, Stephanie B ^a,b   Kuo, Tzy Mey ^b   Meyer, Anne Marie ^a,b   Martens, Christa E ^b   Hassmiller Lich, Kristen M ^a   Tangka, Florence K L ^c   Richardson, Lisa C ^c   Hall, Ingrid J ^c   Smith, Judith Lee ^c   Mayorga, Maria E ^d   Brown, Paul ^e   Crutchfield, Trisha M ^b   Pignone, Michael P ^b,f  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d North Carolina State University   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer screening tests; Colonoscopy; Colorectal cancer; Fecal occult blood test; Medicaid; Medicare; Multilevel analysis

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; FECAL IMMUNOCHEMICAL TEST; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OCCULT BLOOD TEST; ODDS RATIO; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; PUBLIC HEALTH INSURANCE;

EID: 85011818293     PISSN: None     EISSN: 22113355     Source Type: Journal    
DOI: 10.1016/j.pmedr.2016.11.019     Document Type: Article

References (33)

1. Bandi, P., Cokkinides, V., Smith, R.A., Jemal, A., Trends in colorectal cancer screening with home-based fecal occult blood tests in adults ages 50 to 64 years, 2000–2008. Cancer 118:20 (2012), 5092–5099.
2. Boscoe, F.P., Henry, K.A., Zdeb, M.S., A nationwide comparison of driving distance versus straight-line distance to hospitals. Prof. Geogr. 64:2 (2012), 188–196.
3. Bradbury, B.D., Brooks, D.R., Brawarsky, P., Mucci, L.A., Test-retest reliability of colorectal testing questions on the Massachusetts Behavioral Risk Factor Surveillance System (BRFSS). Prev. Med. 41:1 (2005), 303–311.
4. Centers for Disease Control and Prevention, Vital signs: colorectal cancer screening, incidence, and mortality—United States, 2002-2010. MMWR Morb. Mortal. Wkly Rep. 60:26 (2011), 884–889.
5. Centers for Disease Control and Prevention, Vital signs: colorectal cancer screening test use. MMWR, 62(44), 2013, 883.
6. Centers for Medicare and Medicaid Services, CMS, National Coverage Determination (NCD) for colorectal cancer screening tests (210.3). Baltimore (MD). (Publication Number 100-3. Available from:) http://www.cms.gov/medicare-coverage-database/details/ncd-details.aspx?NCDId=281&ncdver=3&NCAId=212&NcaName=Screening+DNA+Stool+Test+for+Colorectal+Cancer&IsPopup=y&bc=AAAAAAAACAAAAA%3D%3D&, 2009 (Accessed: Sep 29, 2014).
7. Centers for Medicare and Medicaid Services, CMS, Colorectal cancer screenings. ([Baltimore (MD) Available From:) https://www.medicare.gov/coverage/colorectal-cancer-screenings.html, 2015 (Accessed: Aug 7).
8. Chacko, L., Macaron, C., Burke, C.A., Colorectal cancer screening and prevention in women. Dig. Dis. Sci. 60:3 (2015), 698–710.
9. Dodou, D., de Winter, J.C., Agreement between self-reported and registered colorectal cancer screening: a meta-analysis. Euro. J. Cancer Care (Engl)., 2014, 10.1111/ecc.12204.
10. ESRI ArcGIS Desktop [computer program]. Version 93 Environmental System Research Institute.
11. Hawley, S., Lillie, S., Cooper, G., Elston Lafata, J., Managed care patients’ preferences, physician recommendations, and colon cancer screening. Am. J. Manag. Care 20:7 (2014), 555–561.
12. Inadomi, J.M., Vijan, S., Janz, N.K., et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch. Intern. Med. 172:7 (2012), 575–582.
13. Kim, J.A., Porterfield, D., Gizlice, Z., Trends in up-to-date status in colorectal cancer screening, North Carolina, 1998–2002. N. C. Med. J. 66:6 (2005), 420–426.
14. Klabunde, C.N., Cronin, K.A., Breen, N., et al. Trends in colorectal cancer test use among vulnerable populations in the United States. Cancer Epidemiol. Biomark. Prev. 20:8 (2011), 1611–1621.
15. Klabunde, C.N., Joseph, D.A., King, J.B., White, A., Plescia, M., Vital signs: colorectal cancer screening test use—United States, 2012. MMWR Morb. Mortal. Wkly Rep. 62:44 (2013), 881–888.
16. Levin, B., Lieberman, D.A., McFarland, B., et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134:5 (2008), 1570–1595.
17. Meissner, H.I., Breen, N., Klabunde, C.N., Vernon, S.W., Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol. Biomark. Prev. 15:2 (2006), 389–394.
18. National Colorectal Cancer Roundtable, Tools & resources – 80% by 2018. (Available from:) http://nccrt.org/tools/80-percent-by-2018/, 2015 (Accessed: Mar, 11).
19. Office of Disease Prevention and Health Promotion ODPHP, Healthy People 2020. Office of Disease Prevention and Health Promotion, 2015 (Available from: https://www.healthypeople.gov/2020/topics-objectives/topic/cancer/objectives. Accessed: Sept 30, 2014).
20. Pignone, M.P., Crutchfield, T.M., Brown, P.M., et al. Using a discrete choice experiment to inform the design of programs to promote colon cancer screening for vulnerable populations in North Carolina. BMC Health Serv. Res., 14(1), 2014, 1.
21. Pruitt, S.L., Leonard, T., Zhang, S., Schootman, M., Halm, E.A., Gupta, S., Physicians, clinics, and neighborhoods: multiple levels of influence on colorectal cancer screening. Cancer Epidemiol. Biomark. Prev. 23:7 (2014), 1346–1355.
22. Reed, A.E., Mikels, J.A., Simon, K.I., Older adults prefer less choice than younger adults. Psychol. Aging 23:3 (2008), 671–675.
23. Schenck, A.P., Klabunde, C.N., Warren, J.L., et al. Data sources for measuring colorectal endoscopy use among Medicare enrollees. Cancer Epidemiol. Biomark. Prev. 16:10 (2007), 2118–2127.
24. Schenck, A.P., Klabunde, C.N., Warren, J.L., et al. Evaluation of claims, medical records, and self-report for measuring fecal occult blood testing among medicare enrollees in fee for service. Cancer Epidemiol. Biomark. Prev. 17:4 (2008), 799–804.
25. Schwartz, B., The Paradox of Choice: Why More Is Less. 2004, Ecco.
26. Shariff-Marco, S., Breen, N., Stinchcomb, D.G., Klabunde, C.N., Multilevel predictors of colorectal cancer screening use in California. Am. J. Manag. Care 19:3 (2013), 205–216.
27. Steele, C.B., Rim, S.H., Joseph, D.A., King, J.B., Seeff, L.C., Colorectal cancer incidence and screening - United States, 2008 and 2010. MMWR Surveill. Summ. 62:Suppl. 3 (2013), 53–60.
28. Towne, S.D. Jr., Smith, M.L., Ory, M.G., Geographic variations in access and utilization of cancer screening services: examining disparities among American Indian and Alaska native elders. Int. J. Health Geogr., 13, 2014, 18, 10.1186/1476-072X-13-18.
29. US Preventive Services Task Force, Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. Ann. Intern. Med., 149(9), 2008, 627.
30. Wernli, K.J., Hubbard, R.A., Johnson, E., et al. Patterns of colorectal cancer screening uptake in newly eligible men and women. Cancer Epidemiol. Biomark. Prev. 23:7 (2014), 1230–1237.
31. Wheeler, S.B., Carpenter, W.R., Peppercorn, J., Schenck, A.P., Weinberger, M., Biddle, A.K., Structural/organizational characteristics of health services partly explain racial variation in timeliness of radiation therapy among elderly breast cancer patients. Breast Cancer Res. Treat. 133:1 (2012), 333–345.
32. Wheeler, S.B., Kuo, T.M., Goyal, R.K., et al. Regional variation in colorectal cancer testing and geographic availability of care in a publicly insured population. Health Place 29 (2014), 114–123.
33. Xu, F., Town, M., Balluz, L.S., et al. Surveillance for certain health behaviors among states and selected local areas - United States, 2010. MMWR Surveill. Summ. 62:1 (2013), 1–247.